<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04784962</url>
  </required_header>
  <id_info>
    <org_study_id>P84082</org_study_id>
    <secondary_id>281309</secondary_id>
    <secondary_id>20CX6284</secondary_id>
    <nct_id>NCT04784962</nct_id>
  </id_info>
  <brief_title>NMES for Rehab After Surgery</brief_title>
  <official_title>Neuromuscular Stimulation for Rehabilitation After General and Vascular Surgery - a Pilot Randomised Clinical Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Imperial College London</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Imperial College London</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      A randomised pilot study assessing the acceptability and feasibility of utilising&#xD;
      neuromuscular stimulation devices to enhance post-operative rehabilitation and recovery after&#xD;
      general, vascular and urological surgery procedures.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients undergoing inpatient rehabilitation after general, vascular or urological surgery&#xD;
      will be invited to take part in a randomised study utilising either sham or active&#xD;
      neuromuscular stimulation devices to enhance post-operative rehabilitation and physiotherapy.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 7, 2021</start_date>
  <completion_date type="Anticipated">November 2022</completion_date>
  <primary_completion_date type="Anticipated">July 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>Sham and active devices are identical and will be randomly allocated</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Acceptability of NMES as an adjunct for rehabilitation</measure>
    <time_frame>Up to discharge from hospital (1 month)</time_frame>
    <description>Qualitiative assessment of participant satisfaction and acceptance of NMES device as an adjunct to standard rehabilitation via semi-structured interview</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to return to baseline mobility and independence</measure>
    <time_frame>Up to discharge from hospital (1 month)</time_frame>
    <description>Time in days to return to pre-operative mobility and independence</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Generic Quality of life - SF-36</measure>
    <time_frame>Up to discharge from hospital (1 month)</time_frame>
    <description>Generic quality of life values at entry and exit of study utilising the Short Form 36 health profile</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Generic Quality of life - EQ-5D</measure>
    <time_frame>Up to discharge from hospital (1 month)</time_frame>
    <description>Generic quality of life values at entry and exit of study utilising the EuroQol 5 Domain (EQ-5D) Health Metric</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Generic Quality of life - EQ VAS</measure>
    <time_frame>Up to discharge from hospital (1 month)</time_frame>
    <description>Generic quality of life values at entry and exit of study utilising the EuroQol Visual Analogue Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional Independence Measure</measure>
    <time_frame>Up to discharge from hospital (1 month)</time_frame>
    <description>Scoring tool of ability to function independently at entry and exit of study</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Barthel Index</measure>
    <time_frame>Up to discharge from hospital (1 month)</time_frame>
    <description>Scoring tool of independence at entry and exit of study</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rockwood Frailty Index</measure>
    <time_frame>Up to discharge from hospital (1 month)</time_frame>
    <description>Frailty index scoring tool at entry and exit of study</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Satisfaction with device</measure>
    <time_frame>Up to discharge from hospital (1 month)</time_frame>
    <description>User satisfaction with NMES device assessed by qualitative feedback and assessment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of stay</measure>
    <time_frame>Up to discharge from hospital (1 month)</time_frame>
    <description>Hospital Length of stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>6 Minute Walk</measure>
    <time_frame>Up to discharge from hospital (1 month)</time_frame>
    <description>Distance walked in 6 minutes at entry and exit of study</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Timed Up and Go</measure>
    <time_frame>Up to discharge from hospital (1 month)</time_frame>
    <description>Time taken to stand and walk from sitting in a chair at entry and exit of study</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Compliance with device usage</measure>
    <time_frame>Up to discharge from hospital (1 month)</time_frame>
    <description>User compliance with NMES device as assessed with usage diary and qualitative feedback</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Q Frailty</measure>
    <time_frame>Up to discharge from hospital (1 month)</time_frame>
    <description>Frailty assessment scale at entry and exit of study</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time taken to achieve - Sitting for &gt;5 minutes</measure>
    <time_frame>Up to discharge from hospital (1 month)</time_frame>
    <description>Mobility Milestone</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Standing for &gt;1 minute</measure>
    <time_frame>Up to discharge from hospital (1 month)</time_frame>
    <description>Mobility Milestone</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Walking &gt;50m</measure>
    <time_frame>Up to discharge from hospital (1 month)</time_frame>
    <description>Mobility Milestone</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Surgery</condition>
  <condition>Vascular Diseases</condition>
  <arm_group>
    <arm_group_label>Control Arm</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Standard rehabilitation care including physiotherapy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intervention Arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Standard rehabilitation care including physiotherapy + Adjunctive Neuromuscular Stimulation Device Usage</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Revitive Medic Neuromuscular Stimulation Device</intervention_name>
    <description>Usage of the Revitive NMES device - 2-6 sessions daily (1-3 hours per day).</description>
    <arm_group_label>Intervention Arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria&#xD;
&#xD;
          -  Medically stable after index surgery&#xD;
&#xD;
          -  Willing and able to participate in study protocol&#xD;
&#xD;
          -  All ethnic groups, male or female above the age of 18 years&#xD;
&#xD;
          -  Baseline Rockwood Frailty Score of 3 or greater&#xD;
&#xD;
        Exclusion Criteria&#xD;
&#xD;
          -  Inability or unwillingness to participate in trial&#xD;
&#xD;
          -  Implanted electrical device such as Pacemaker or defibrillator.&#xD;
&#xD;
          -  Pregnant&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alun H Davies, DM DSC FRCS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Imperial College London</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tristan RA Lane, PhD FRCS</last_name>
    <phone>020 3311 7309</phone>
    <email>tristan.lane@imperial.ac.uk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sarrah H Peerbux, BSc</last_name>
    <phone>02033117371</phone>
    <email>s.peerbux@imperial.ac.uk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Imperial College Healthcare NHS Trust</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Megumi Nimura</last_name>
      <email>m.nimura@imperial.ac.uk</email>
    </contact>
    <investigator>
      <last_name>Alun H Davies</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>February 23, 2021</study_first_submitted>
  <study_first_submitted_qc>March 3, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 5, 2021</study_first_posted>
  <last_update_submitted>August 24, 2021</last_update_submitted>
  <last_update_submitted_qc>August 24, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>rehabilitation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vascular Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Anonymised data will be available following publication to requesting researchers.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>After publication and analysis complete.</ipd_time_frame>
    <ipd_access_criteria>On request from Academic Institutions</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

